| Antimicrobial activity of the metals and metal oxide nanoparticles SM Dizaj, F Lotfipour, M Barzegar-Jalali, MH Zarrintan, K Adibkia Materials Science and Engineering: C 44, 278-284, 2014 | 1625 | 2014 |
| Calcium carbonate nanoparticles as cancer drug delivery system S Maleki Dizaj, M Barzegar-Jalali, MH Zarrintan, K Adibkia, F Lotfipour Expert opinion on drug delivery 12 (10), 1649-1660, 2015 | 282 | 2015 |
| Calcium carbonate nanoparticles; potential applications in bone and tooth disorders S Maleki, M Barzegar-Jalali, MH Zarrintan, K Adibkia, F Lotfipour Pharmaceutical Sciences 20 (4), 175-182, 2015 | 112 | 2015 |
| Ciprofloxacin HCl-loaded calcium carbonate nanoparticles: preparation, solid state characterization, and evaluation of antimicrobial effect against Staphylococcus aureus S Maleki Dizaj, F Lotfipour, M Barzegar-Jalali, MH Zarrintan, K Adibkia Artificial cells, nanomedicine, and biotechnology 45 (3), 535-543, 2017 | 88 | 2017 |
| Physicochemical characterization and antimicrobial evaluation of gentamicin-loaded CaCO3 nanoparticles prepared via microemulsion method SM Dizaj, F Lotfipour, M Barzegar-Jalali, MH Zarrintan, K Adibkia Journal of Drug Delivery Science and Technology 35, 16-23, 2016 | 65 | 2016 |
| Antimicrobial studies of metal and metal oxide nanoparticles VV Kumar, SP Anthony Surface chemistry of nanobiomaterials, 265-300, 2016 | 53 | 2016 |
| Preparation and evaluation of novel metronidazole sustained release and floating matrix tablets S Asnaashari, NS Khoei, MH Zarrintan, K Adibkia, Y Javadzadeh Pharmaceutical development and technology 16 (4), 400-407, 2011 | 52 | 2011 |
| Evaluation of drug release kinetics and physico-chemical characteristics of metronidazole floating beads based on calcium silicate and gas-forming agents Y Javadzadeh, S Hamedeyazdan, K Adibkia, F Kiafar, MH Zarrintan, ... Pharmaceutical Development and Technology 15 (4), 329-338, 2010 | 52 | 2010 |
| Application of Box–Behnken design to prepare gentamicin-loaded calcium carbonate nanoparticles S Maleki Dizaj, F Lotfipour, M Barzegar-Jalali, MH Zarrintan, K Adibkia Artificial cells, nanomedicine, and biotechnology 44 (6), 1475-1481, 2016 | 50 | 2016 |
| Box-Behnken experimental design for preparation and optimization of ciprofloxacin hydrochloride-loaded CaCO3 nanoparticles SM Dizaj, F Lotfipour, M Barzegar-Jalali, MH Zarrintan, K Adibkia Journal of drug delivery science and technology 29, 125-131, 2015 | 48 | 2015 |
| Identifying outcome-based indicators and developing a curriculum for a continuing medical education programme on rational prescribing using a modified Delphi process HM Esmaily, C Savage, R Vahidi, A Amini, MH Zarrintan, R Wahlstrom BMC Medical education 8, 1-8, 2008 | 47 | 2008 |
| Nanostructured lipid carrier for topical application of N-acetyl glucosamine L Aliasgharlou, S Ghanbarzadeh, H Azimi, MH Zarrintan, H Hamishehkar Advanced pharmaceutical bulletin 6 (4), 581, 2016 | 28 | 2016 |
| Helicobacter pylori nanoparticles as a potential treatment of conventional multiple sclerosis. MZ Pezeshki, S Zarrintan, MH Zarrintan Medical hypotheses 70 (6), 1223-1223, 2008 | 23 | 2008 |
| Water vapor adsorption and desorption isotherms of biologically active proteins CD Teng, MH Zarrintan, MJ Groves Pharmaceutical research 8, 191-195, 1991 | 22 | 1991 |
| The effect of compactional pressure on a wheat germ lipase preparation MH Zarrintan, CD Teng, MJ Groves Pharmaceutical research 7, 247-250, 1990 | 19 | 1990 |
| N-Diethylmethyl chitosan for gene delivery to pancreatic cancer cells and the relation between charge ratio and biologic properties of polyplexes via interpolations polynomial S Safari, FA Dorkoosh, M Soleimani, MH Zarrintan, H Akbari, B Larijani, ... International journal of pharmaceutics 420 (2), 350-357, 2011 | 17 | 2011 |
| Evaluation and optimization of chitosan derivatives-based gene delivery system via kidney epithelial cells S Safari, MH Zarrintan, M Soleimani, FA Dorkoosh, H Akbari, B Larijani, ... Advanced pharmaceutical bulletin 2 (1), 7, 2012 | 14 | 2012 |
| Abu Bakr Muhammad ibn Zakariya Razi (AD 865–925) and early description of clinical trials S Zarrintan, F Najjarian, S Tahmasebzadeh, S Aslanabadi, MH Zarrintan International journal of cardiology 174 (3), 758-759, 2014 | 11 | 2014 |
| Bani Adam: Saadi Shirazi (AD 1184–1283/1291) and the concept of empathy S Zarrintan, F Ranjbar, S Aslanabadi, MH Zarrintan Child's Nervous System 31, 1211-1212, 2015 | 5 | 2015 |
| The effect of pore-formers and plasticizers on the release kinetic of diltiazem hydrochloride from the controlled porosity osmotic pumps J Shokri, MH Zarrintan, S Ghanbarzadeh, Z Arash, A Farahani, K Adibkia Drug research, 414-419, 2013 | 5 | 2013 |
